Form 8-K - Current report:
SEC Accession No. 0001213900-25-051350
Filing Date
2025-06-05
Accepted
2025-06-05 07:00:07
Documents
12
Period of Report
2025-06-04
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0244752-8k_kronos.htm   iXBRL 8-K 29850
  Complete submission text file 0001213900-25-051350.txt   197573

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE kron-20250604.xsd EX-101.SCH 3017
3 XBRL LABEL FILE kron-20250604_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE kron-20250604_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0244752-8k_kronos_htm.xml XML 3679
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 251025004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)